Filing summary
Entity and period mismatch: The supplied filing is Vickers Vantage Corp. I’s Form 10-K for the fiscal year ended December 31, 2020—not a Scilex Holding Co. filing. It describes a pre-revenue SPAC. The filing also contains inconsistent entity and officer references in its signature pages; investors should confirm the registrant and filing identity before relying on it.
Business context and reporting period
Vickers Vantage Corp. I was incorporated in February 2020 to seek a merger, acquisition, or similar business combination. It had no operating business at December 31, 2020. Its IPO closed on January 11, 2021, after the reporting date, raising $138.0 million from units and $5.13 million from private warrants. The company placed $139.38 million in trust, or $10.10 per public share.
Financial results and liquidity
- Results: From inception through December 31, 2020, formation and operating costs and net loss were $6,276. No revenue was reported; the filing says operating revenue was not expected before a business combination.
- Cash flow: Net cash used in operating activities was $1,276; financing activities provided $31,787; ending cash was $30,511.
- Balance sheet: Total assets were $199,484, including $30,511 cash and $168,973 deferred offering costs. Total current liabilities were $180,760, including $125,000 due under a related-party note, $30,000 in related-party advances, and $25,760 accrued offering costs. Shareholders’ equity was $18,724.
- Debt and liquidity: The company reported no long-term debt or off-balance-sheet financing arrangements. The $125,000 related-party note was repaid after the IPO, on January 14, 2021. IPO proceeds and trust balances are subsequent-period events, not December 31, 2020 cash or assets.
- Margins and comparison: Not meaningful for this pre-operating company. The filing presents an inception-to-year-end period and provides no prior comparable operating period.
Material changes, outlook, and risks
The main subsequent change was the January 2021 IPO and private placement. Transaction costs totaled $8.15 million, including $5.19 million of deferred underwriting fees payable only if a business combination closes. No operating forecast or target-business guidance is provided.
Management stated that mandatory liquidation if no business combination is completed raises substantial doubt about the company’s ability to continue as a going concern. It had until January 11, 2022 to complete a combination, with up to two three-month extensions to July 11, 2022, subject to sponsor funding of $1.035 million per extension. Sponsor funding was not assured. Other material risks include failure to find or close a suitable transaction, redemptions reducing available cash, competition among SPACs, COVID-19 uncertainty, conflicts of interest, dilution from warrants or new securities, and potential loss of the public investment upon liquidation. Warrants would expire worthless if no combination is completed.
The company reported no legal proceedings, no dividends, and effective disclosure controls as of year-end. Its auditor issued an unqualified opinion on the financial statements but did not audit internal control over financial reporting.
Key facts for investors to verify
- Confirm the registrant: this text identifies Vickers Vantage Corp. I, not Scilex Holding Co., and includes inconsistent signature-page names.
- Review the audited financial statements and notes, especially the going-concern disclosure and related-party balances and repayment.
- Verify the IPO trust funding, deferred underwriting fees, extension terms, and actual availability of sponsor loans.
- Check subsequent filings for any business combination, extensions, redemptions, or changes to share and warrant terms.
- Assess potential dilution, redemption limits, sponsor conflicts, and the possibility that public warrants become worthless.